These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 28248176)

  • 21. Powerful Ideas for Global Access to Medicines.
    Moon S
    N Engl J Med; 2017 Feb; 376(6):505-507. PubMed ID: 28099819
    [No Abstract]   [Full Text] [Related]  

  • 22. Chemical philanthropy: a path forward for antibiotic discovery?
    Hansford KA; Blaskovich MA; Cooper MA
    Future Med Chem; 2016 Jun; 8(9):925-9. PubMed ID: 27228160
    [No Abstract]   [Full Text] [Related]  

  • 23. The global need for effective antibiotics-moving towards concerted action.
    Cars O; Hedin A; Heddini A
    Drug Resist Updat; 2011 Apr; 14(2):68-9. PubMed ID: 21444235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using sound for microbial eradication--light at the end of the tunnel?
    Harris F; Dennison SR; Phoenix DA
    FEMS Microbiol Lett; 2014 Jul; 356(1):20-2. PubMed ID: 24861483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Reduction of antibiotics in the world].
    Speksnijder DC; Wagenaar JA
    Tijdschr Diergeneeskd; 2013 Sep; 138(9):42. PubMed ID: 24133773
    [No Abstract]   [Full Text] [Related]  

  • 26. Proposals seek to reduce resistance, boost development of new antibiotics.
    Kuehn BM
    JAMA; 2011 May; 305(18):1845-6. PubMed ID: 21558509
    [No Abstract]   [Full Text] [Related]  

  • 27. [Recent results of multinational studies on antibiotic resistance: should we have "PROTECTion" against these resistances?].
    Marchese A; Schito GC
    Med Mal Infect; 2007 Nov; 37 Spec No 1():2-5. PubMed ID: 18376502
    [No Abstract]   [Full Text] [Related]  

  • 28. Trade is central to achieving the sustainable development goals: a case study of antimicrobial resistance.
    Hanefeld J; Khan M; Tomson G; Smith R
    BMJ; 2017 Jul; 358():j3505. PubMed ID: 28739673
    [No Abstract]   [Full Text] [Related]  

  • 29. Antimicrobial stewardship: English Surveillance Programme for Antimicrobial Utilization and Resistance (ESPAUR).
    Ashiru-Oredope D; Hopkins S;
    J Antimicrob Chemother; 2013 Nov; 68(11):2421-3. PubMed ID: 24027247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug development: Time for teamwork.
    May M
    Nature; 2014 May; 509(7498):S4-5. PubMed ID: 24784427
    [No Abstract]   [Full Text] [Related]  

  • 31. What's old is new: Reconfiguring known antibiotics to fight drug resistance.
    Chakradhar S
    Nat Med; 2016 Nov; 22(11):1197-1199. PubMed ID: 27824813
    [No Abstract]   [Full Text] [Related]  

  • 32. Economic Incentives for Antibacterial Drug Development: Literature Review and Considerations From the Transatlantic Task Force on Antimicrobial Resistance.
    Sciarretta K; Røttingen JA; Opalska A; Van Hengel AJ; Larsen J
    Clin Infect Dis; 2016 Dec; 63(11):1470-1474. PubMed ID: 27578820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial espionage?
    Lancet; 2015 Feb; 385(9970):746. PubMed ID: 25752155
    [No Abstract]   [Full Text] [Related]  

  • 34. The drug push.
    Servick K
    Science; 2015 May; 348(6237):850-3. PubMed ID: 25999488
    [No Abstract]   [Full Text] [Related]  

  • 35. A Common Platform for Antibiotic Dereplication and Adjuvant Discovery.
    Cox G; Sieron A; King AM; De Pascale G; Pawlowski AC; Koteva K; Wright GD
    Cell Chem Biol; 2017 Jan; 24(1):98-109. PubMed ID: 28017602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Report urges controversial 'delinkage' to foster new antibiotics.
    Holmes D
    Nat Med; 2014 Apr; 20(4):320. PubMed ID: 24710363
    [No Abstract]   [Full Text] [Related]  

  • 37. The impact of the United Nations Convention on Biological Diversity on natural products research.
    Cragg GM; Katz F; Newman DJ; Rosenthal J
    Nat Prod Rep; 2012 Dec; 29(12):1407-23. PubMed ID: 23037777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GAIN Act legislation: is it enough?
    Tillotson GS
    Lancet Infect Dis; 2012 Nov; 12(11):823-4. PubMed ID: 23099071
    [No Abstract]   [Full Text] [Related]  

  • 39. Antibiotic resistance is ancient: implications for drug discovery.
    Wright GD; Poinar H
    Trends Microbiol; 2012 Apr; 20(4):157-9. PubMed ID: 22284896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Number of agents being developed to combat drug resistant bacteria is "alarmingly low," warns report.
    McCarthy M
    BMJ; 2013 Apr; 346():f2548. PubMed ID: 23604164
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.